Delivery Order SPE2DB24D9241-SPE2DB25FHGLL
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,134.20 contract is for the delivery of YF-VAX 1 dose vials, with a performance period ending on April 28, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,783.55 contract is for the supply of YF-VAX 1 dose vials, a specialized vaccine product. DMS Pharmaceutical Group Inc. is a key pharmaceutical supplier to the Department of Defense (DoD), holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of branded and generic prescription drugs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,670.13 contract is for the delivery of 4567790722 units of YF-VAX 1 dose vials, with a completion date of April 15, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $33,402.60 contract is for the delivery of YF-VAX 1 dose vials, a specialized vaccine product, with a completion date of February 24, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,634.90 contract is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product, with a period of performance through December 12, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $16,701.30 contract is for the supply of 4567419891 YF-VAX 1 dose vials, with a performance period through March 18, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the issuance of delivery orders for a comprehensive range...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,670.13 and covers the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product, with a period of performance through February 13, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,113.42 contract is for the delivery of 4567870435 YF-VAX 1 dose vials, a specialized pharmaceutical product, with a period of performance through April 29, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $27,835.50 contract is for the supply of 4,567,268,544 doses of the YF-VAX 1 DOSE VIALS product, with a performance period ending on March 6, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,113.42, is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 27, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
- SPE2DB24D9241Indefinite Delivery Contract
- SPE2DB24D9241-SPE2DB25FHGLLDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,783.55 contract is for the delivery of YF-VAX 1 dose vials, with a period of performance through July 23, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities. As a woman-owned small business, DMS Pharmaceutical Group has secured this contract without any set-aside designation, demonstrating its ability to compete effectively in the federal procurement market for pharmaceutical products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/1/25 |